Monte Rosa Therapeutics, Inc. (GLUE)
18.81
-0.07
(-0.37%)
USD |
NASDAQ |
May 22, 16:00
18.80
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics EPS Diluted (Quarterly) : -0.4456 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Myriad Genetics, Inc. | -0.3639 |
| BioRestorative Therapies, Inc. | -0.1215 |
| Kyntra Bio, Inc. | -3.755 |
| Kura Oncology, Inc. | -0.8276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.50M |
| Revenue (Quarterly) | 4.21M |
| Total Expenses (Quarterly) | 48.71M |
| Enterprise Value | 961.90M |
| Gross Profit Margin (Quarterly) | 51.81% |
| Profit Margin (Quarterly) | -1.06K% |
| Earnings Yield | -8.65% |
| Normalized Earnings Yield | -8.653 |